The BHF have recently launched their Translational Grants which aim to accelerate the pre-clinical development of cardiovascular technologies, comprising
- therapeutics, including the repurposing of existing therapeutics for a novel cardiovascular indication,
- diagnostics including biomarkers,
- imaging technologies,
- algorithms and computer modelling
They hope to de-risk each technology for a relatively small sum (proposals in the region of £250k are welcomed) to increase attractiveness for external follow-on-funding.
Proposed technologies should address an unmet clinical need, have robust, repeatable proof of concept in vitro or in vivo data and have a novel, patented or patentable inventive step.
Applications are assessed via a two stage process, and the outline application is available online. There is no deadline – applications will be reviewed asap following receipt and outcomes are anticipated within 3-6 months.
Any application should be made in conjunction with the institutional Tech Transfer Office – either Claire Fenlon (email@example.com / 46804) or Jonathan Watkins (firstname.lastname@example.org / 49090) would be happy to discuss any potential application. In addition, the BHF now have a dedicated Research Translation Advisor, Victoria Taylor, who will be able to advise early on whether your research is at the appropriate stage or is eligible for funding – Victoria can be contacted on email@example.com